Pharmacokinetics of Plant-based Ingredient
Exploratory Study to Assess the Pharmacokinetics in Relation to Blood Glucose and Insulin Levels After Intake of a Plant-based Ingredient in Healthy Subjects
1 other identifier
interventional
20
1 country
1
Brief Summary
The study is designed to explore the pharmacokinetics of a Plant-based ingredient in two different matrices, at different dose levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Jun 2014
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2014
CompletedStudy Start
First participant enrolled
June 1, 2014
CompletedFirst Posted
Study publicly available on registry
June 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedFebruary 18, 2015
June 1, 2014
4 months
April 29, 2014
February 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
AUC of the plant based ingredient calculated by a non-compartmental model
predose, 15min, 30min, 45min, 1h, 1.5hrs, 2hrs, 3hrs, 5hrs, 8hrs, 12hrs.
Secondary Outcomes (2)
AUC of the plant based ingredient calculated by a compartmental model
predose, 15min, 30min, 45min, 1hr, 1.5hrs, 2hrs, 3hrs, 5hrs, 8hrs, 12hrs.
Urinary excretion of Plant-based ingredient
24 hours
Other Outcomes (4)
AUC of the plant based ingredient calculated by a population model
predose, 15min, 30min, 45min, 1hr, 1.5hrs, 2hrs, 3hrs, 5hrs, 8hrs, 12hrs.
Describe the time course of the effect on glucose and insulin levels in response to the intake of plant based ingredient
predose, 15min, 30min, 45min, 1hr, 1.5hrs, 2hrs, 3hrs, 5hrs, 8hrs, 12hrs.
+iAUC Blood glucose
120 minutes and 180 minutes
- +1 more other outcomes
Study Arms (5)
No added Plant-based ingredient
PLACEBO COMPARATORNo Plant-based ingredient added to starchy meal
Low dose added to starchy meal
ACTIVE COMPARATORPlant-based ingredient in low dose added to starchy meal
High dose added to starchy meal
ACTIVE COMPARATORPlant-based ingredient in high dose added to starchy meal
Low dose added to liquid
ACTIVE COMPARATORPlant-based ingredient in low dose added to liquid
High dose added to liquid
ACTIVE COMPARATORPlant-based ingredient in high dose added to liquid
Interventions
Eligibility Criteria
You may qualify if:
- Healthy males, age at start of the study 20 and 50 years
- Body mass index (BMI) ≥ 20,0 and ≤ 25,0 kg/m2
- Apparently healthy: no medical conditions which might affect the study measurements, absorption, metabolism and distribution (including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases)
- Fasting blood glucose value of subjects is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening
You may not qualify if:
- Any history of diabetes, hyper- (or hypo-) glycemia or other disorder of glucose metabolism
- Any history of gastro-intestinal disorders (including frequent diarrhoea for example)
- Blood donation in the past 2 months
- Reported participation in another nutritional or biomedical trial 3 months before the pre-study examination or during the study
- Reported intense sporting activities \> 10 h/w
- Consumption of \> 21 alcoholic drinks in a typical week
- Not being used to eat breakfast
- Reported use of any nicotine containing products in the six months preceding the study and during the study itself
- Use of medication which interferes with study measurements
- Reported dietary habits: medically prescribed diet, slimming diet
- Not used to eat 3 meals a day
- Vegetarian
- Reported weight loss/gain (\>10%) in the last six month before the study;
- Allergy or intolerance to food products and aversion to food products;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unilever R&Dlead
Study Sites (1)
Eurofins OPTIMED
Gierre, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2014
First Posted
June 20, 2014
Study Start
June 1, 2014
Primary Completion
October 1, 2014
Study Completion
October 1, 2014
Last Updated
February 18, 2015
Record last verified: 2014-06